Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Integrating Health Care and Social Services for People with ...
Released: January 10, 2019
The Roundtable on Quality Care for People with Serious Illness of the National Academies of Sciences, Engineering, and Medicine held a public workshop on July 19, 2018 to explore the challenges and opportunities related to integrating health care and social services for people with serious illness.
Considerations for the Design of a Systematic Review of Care ...
Released: December 05, 2018
Research on care interventions for individuals with Alzheimer's disease and related dementias, as well as on interventions aimed at their caregivers, has expanded tremendously in recent years. The National Institute on Aging has initiated a study with the National Academies of Sciences, Engineering, and Medicine to take stock of the current state of knowledge and inform decision making about which care interventions for individuals with dementia and their caregivers are ready for dissemination and implementation on a broad scale.
Harnessing Mobile Devices for Nervous System Disorders ...
Released: November 19, 2018
To explore current developments and opportunities for using mobile technology to advance research and treatment of central nervous system (CNS) disorders, the National Academies’ Forum on Neuroscience and Nervous System Disorders hosted a workshop on June 5–6, 2018.
Implementing Quality Measures for Accountability in ...
Released: October 01, 2018
The Roundtable on Quality Care for People with Serious Illness of the National Academies of Sciences, Engineering and Medicine held a public workshop on April 17, 2018 in Washington, D.C., to explore the challenges and opportunities related to implementing quality measures for accountability purposes in community-based care for people with serious illness.
Neuroforensics: Exploring the Legal Implications of Emerging ...
Released: July 06, 2018
On March 6, 2018, the Forum on Neuroscience and Nervous System Disorders, in collaboration with the Committee on Science, Technology, and Law (CSTL), held a public workshop to explore and advance efforts to identify and evaluate the potential effects of emerging neurotechnologies on the legal system.
Physician-Assisted Death: Scanning the Landscape ...
Released: June 27, 2018
As a matter of public opinion and of public policy, a national dialogue is taking place around the question of whether, and under what circumstances, terminally ill patients can access life-ending medications with the aid of a physician. This publication summarizes the presentations and discussions from a workshop of the National Academies of Sciences, Engineering, and Medicine. The workshop explored what is known and not known empirically about the practice of physician-assisted death, as well as some of the moral and ethical considerations regarding the practice.
Financing and Payment Strategies to Support High-Quality ...
Released: May 16, 2018
Those facing serious illness have a range of interconnected medical and non-medical needs, and the way their care is financed has a large impact on the care they receive. Medicare is the predominant payer, but both Medicaid and private payers also play significant roles in financing care for serious illness. In an effort to address the complex needs of people with serious illness, public and private health care payers are testing innovative financing strategies and alternative payment models.
Advancing Therapeutic Development for Pain and Opioid Use ...
Released: March 23, 2018
Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. In parallel with increasing recognition of the need to treat chronic pain, the opioid epidemic has emerged as a growing public health emergency. In 2017, the National Institutes of Health began exploring public-private partnerships to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To help inform this effort, the National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together experts and stakeholders from academia, federal agencies, advocacy organizations, and companies developing therapeutics for pain and opioid use disorders.
Aging and Disability: Beyond Stereotypes to Inclusion ...
Released: March 13, 2018
How do stereotypes affect the health and independence of aging adults and those with disabilities? How do they impact the industries that interact with these populations? And what are some opportunities to disrupt the narrative and change perceptions of what it means to be older or have a disability?
Enabling Novel Treatments for Nervous System Disorders by ...
Released: March 08, 2018
The blood-brain barrier (BBB) presents a special challenge to the development of therapeutics for many central nervous system (CNS) disorders. Far from acting simply as a physical barrier, the BBB is a complex dynamic system involving several cell types, passive and active transport mechanisms, and adaptive function to control the exchange of substances between the blood and the CNS. Few therapeutic agents readily traverse the BBB to reach the brain or spinal cord, including most small molecule drugs and the vast majority of large molecules such as proteins.